Senior insider sale
EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC — senior position signals high conviction
$603.3K
27.42K shares
What this filing means
DREYER SCOTT plans to sell 27.42K shares of COLLEGIUM PHARMACEUTICAL, INC valued at approximately $603.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/30/2026ACC: 0001959173-26-007152
Officer· EVP & Chief Commercial Officer
Since Jul 2018
27.42K
Shares to sell
$603.3K
Approx. market value
27.42K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
9/23/2026
27.42KTotal acquired27.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/23/2026 | Restricted Stock Vesting Compensation | 27.42K | — |
| Total | 27.42K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
27.42K
Market value
$603.3K
9/30/2026
Total
Units
27.42K
Value
$603.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/30/2026 | 27.42K | $603.3K | NASDAQ | Planned |
| Total | 27.42K | $603.3K | ||